Markets

Ipsen 9-month Sales Up

October 26, 2023 — 01:36 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - French biopharmaceutical company Ipsen SA (IPSEY) Thursday reported 4.6 percent growth in total sales for nine months, on reported basis. Sales grew 7.1 percent at constant exchange rates, driven by the performance of the growth platforms-Dysport, Decapeptyl, Cabometyx and Onivyde.

Year-to-date, Ipsen's total sales reached 2.30 billion euros, nearly 5 percent higher than last year's 2.20 billion euros.

For the third quarter, the company's total sales edged down by 0.3 percent to 772.4 million euros, on reported basis, while it was up 6.5 percent at constant exchange rates.

Looking ahead to the full year, the company said it is confirming its sales guidance, expecting total sales growth greater than 6.0 percent, at constant exchange rates.

RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source

Tags

Markets
Stocks Mentioned

Latest Articles
Data is currently not available